FocusRx | Customized Career Coaching
?? ‘FocusRx’ on YouTube, LinkedIn, Instagram, and TikTok Resume Templates, personalized resume reviews, 1-on-1 coaching, and courses ? www.focusrxpharma.com/
Subscribers: 15K Videos: 204 Total views: 1M Gravity: 74*
Channel URL: https://www.youtube.com/c/focusrx/
Channel ID: UC0ZpTXIPeVdQqKPIVUrTjiQ
Channel's country: 
United States
Channel was established: 13 October 2019.
Channel's estimated monthly earnings: $29.36†
Channel's Videos
rating from 23 viewers
Related Channels
Cass Thompson Career Advice
474 videos
128,000 subscribers
13,071,283 total views
Get2College
175 videos
1,000 subscribers
145,088 total views
TopResume
94 videos
2,440 subscribers
719,546 total views
Resumes To You
28 videos
1,040 subscribers
13,580 total views
Xamplio
31 videos
28,100 subscribers
10,866,675 total views
30 Seconds to Impress
9 videos
4,700 subscribers
1,906,956 total views
CareerCenterUNewHaven
43 videos
1,140 subscribers
668,074 total views
JobInterviewSite
86 videos
8,640 subscribers
3,073,801 total views
Stacy Jene
12 videos
4,070 subscribers
260,014 total views
Paddy Jobsman
727 videos
14,300 subscribers
1,485,677 total views
Diana YK Chan
483 videos
4,080 subscribers
761,869 total views
Chrissy Scivicque
76 videos
2,700 subscribers
559,195 total views
About this Data
*Gravity is FindAChannel's estimation of how engaging a channel's content is. It helps smaller channels with very engaging content compete with much larger channels. Gravity runs on a percentage scale, with 100% being the highest.
†A channel's earnings as shown on FindAChannel are just a rough estimate. There are many factors that will affect how much a channel will actually earn. It is possible that this channel may earn up to 10x as much as our estimated figure. Channel owners may also generate additional income from their channels by using endorsements, merchandise or promotion of affiliate offers.
FocusRx | Customized Career Coaching added to FindAChannel 06 April 2021 (Channel #11286). Entry last modified 17 October 2024.
